Stateside's Canadian Microcap Board Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Stateside's Canadian Microcap Board

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: statesidereport who wrote (1591)	4/13/2016 4:33:32 PM
From: PoorOpinion	Read Replies (1) of 1728

Given that the trials happened 1999-2003 it looks like people have been undervaluing these results for quite a while. It's a mystery to me why this happens, maybe Wiseman is a great clinician but a horrible salesman its not uncommon for researchers to struggle to translate their science from academia to business? Going back to my idea that this is a great clinical/scientific story but slightly wonky business story, this delay was one of the red flags (bought the shares anyway, lol). I guess science gets you so far but the right team (including investors) to interact with the market is also essential, I often find it hard to assess that part of a biotech. I guess they got to the verge of starting the clinical trial, which is something. Just hoping for something better going forward, or the data from the new trial to be irresistible.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next